Intratumoral injection of melatonin enhances tumor regression in cell line-derived and patient-derived xenografts of head and neck cancer by increasing mitochondrial oxidative stress
Martinez-Ruiz L, Florido J, Rodriguez-Santana C, López-Rodríguez A, Guerra-Librero A, Fernández-Gil BI, García-Tárraga P, Garcia-Verdugo JM, Oppel F, Sudhoff H, Sánchez-Porras D, et al. (2023)
Biomedicine & Pharmacotherapy 167: 115518.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Martinez-Ruiz, Laura;
Florido, Javier;
Rodriguez-Santana, César;
López-Rodríguez, Alba;
Guerra-Librero, Ana;
Fernández-Gil, Beatriz I.;
García-Tárraga, Patricia;
Garcia-Verdugo, José Manuel;
Oppel, Felix;
Sudhoff, Holger;
Sánchez-Porras, David;
Ten-Steve, Amadeo
Alle
Alle
Erscheinungsjahr
2023
Zeitschriftentitel
Biomedicine & Pharmacotherapy
Band
167
Art.-Nr.
115518
ISSN
07533322
Page URI
https://pub.uni-bielefeld.de/record/2983011
Zitieren
Martinez-Ruiz L, Florido J, Rodriguez-Santana C, et al. Intratumoral injection of melatonin enhances tumor regression in cell line-derived and patient-derived xenografts of head and neck cancer by increasing mitochondrial oxidative stress. Biomedicine & Pharmacotherapy. 2023;167: 115518.
Martinez-Ruiz, L., Florido, J., Rodriguez-Santana, C., López-Rodríguez, A., Guerra-Librero, A., Fernández-Gil, B. I., García-Tárraga, P., et al. (2023). Intratumoral injection of melatonin enhances tumor regression in cell line-derived and patient-derived xenografts of head and neck cancer by increasing mitochondrial oxidative stress. Biomedicine & Pharmacotherapy, 167, 115518. https://doi.org/10.1016/j.biopha.2023.115518
Martinez-Ruiz, Laura, Florido, Javier, Rodriguez-Santana, César, López-Rodríguez, Alba, Guerra-Librero, Ana, Fernández-Gil, Beatriz I., García-Tárraga, Patricia, et al. 2023. “Intratumoral injection of melatonin enhances tumor regression in cell line-derived and patient-derived xenografts of head and neck cancer by increasing mitochondrial oxidative stress”. Biomedicine & Pharmacotherapy 167: 115518.
Martinez-Ruiz, L., Florido, J., Rodriguez-Santana, C., López-Rodríguez, A., Guerra-Librero, A., Fernández-Gil, B. I., García-Tárraga, P., Garcia-Verdugo, J. M., Oppel, F., Sudhoff, H., et al. (2023). Intratumoral injection of melatonin enhances tumor regression in cell line-derived and patient-derived xenografts of head and neck cancer by increasing mitochondrial oxidative stress. Biomedicine & Pharmacotherapy 167:115518.
Martinez-Ruiz, L., et al., 2023. Intratumoral injection of melatonin enhances tumor regression in cell line-derived and patient-derived xenografts of head and neck cancer by increasing mitochondrial oxidative stress. Biomedicine & Pharmacotherapy, 167: 115518.
L. Martinez-Ruiz, et al., “Intratumoral injection of melatonin enhances tumor regression in cell line-derived and patient-derived xenografts of head and neck cancer by increasing mitochondrial oxidative stress”, Biomedicine & Pharmacotherapy, vol. 167, 2023, : 115518.
Martinez-Ruiz, L., Florido, J., Rodriguez-Santana, C., López-Rodríguez, A., Guerra-Librero, A., Fernández-Gil, B.I., García-Tárraga, P., Garcia-Verdugo, J.M., Oppel, F., Sudhoff, H., Sánchez-Porras, D., Ten-Steve, A., Fernández-Martínez, J., González-García, P., Rusanova, I., Acuña-Castroviejo, D., Carriel, V.S., Escames, G.: Intratumoral injection of melatonin enhances tumor regression in cell line-derived and patient-derived xenografts of head and neck cancer by increasing mitochondrial oxidative stress. Biomedicine & Pharmacotherapy. 167, : 115518 (2023).
Martinez-Ruiz, Laura, Florido, Javier, Rodriguez-Santana, César, López-Rodríguez, Alba, Guerra-Librero, Ana, Fernández-Gil, Beatriz I., García-Tárraga, Patricia, Garcia-Verdugo, José Manuel, Oppel, Felix, Sudhoff, Holger, Sánchez-Porras, David, Ten-Steve, Amadeo, Fernández-Martínez, José, González-García, Pilar, Rusanova, Iryna, Acuña-Castroviejo, Darío, Carriel, Víctor S., and Escames, Germaine. “Intratumoral injection of melatonin enhances tumor regression in cell line-derived and patient-derived xenografts of head and neck cancer by increasing mitochondrial oxidative stress”. Biomedicine & Pharmacotherapy 167 (2023): 115518.
Daten bereitgestellt von European Bioinformatics Institute (EBI)
Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
References
Daten bereitgestellt von Europe PubMed Central.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Quellen
PMID: 37717534
PubMed | Europe PMC
Suchen in